Psychedelic Assisted Therapy: Last Week Tonight with John Oliver (HBO)

Psychedelic-assisted therapy is currently undergoing a resurgence in clinical interest, yet the history of these substances is marked by decades of cultural stigma, propaganda, and restrictive legal developments. Initial research in the mid-20th century explored the therapeutic potential of compounds like LSD and MDMA for conditions such as alcoholism and PTSD. However, the association of psychedelics with the counterculture led to widespread prohibition under the Controlled Substances Act, which stifled scientific inquiry for years. Today, clinical trials are reviving the study of these substances with encouraging early results. Proper implementation requires a carefully controlled therapeutic setting, rather than simple self-administration, to manage the intense and sometimes distressing experiences induced. A key challenge remains the ethical landscape of corporate involvement, as companies maneuver to patent not only specific drug formulations but also the methodology of the therapy itself. Protecting patient access and maintaining rigorous ethical standards is critical to the future of these treatments.